Redhill Biopharma - ADR

-0.09 (-1.82%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)227.51M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$24.51 Million
Adjusted EPS-$0.47
See more estimates
10-Day MA$4.85
50-Day MA$6.42
200-Day MA$7.21
See more pivots

Redhill Biopharma - ADR Stock, NASDAQ:RDHL

21 Ha'arba'a Street, Tel Aviv, Tel Aviv 6473921
Phone: +972.3.541.3131
Number of Employees:


RedHill Biopharma Ltd. is a biopharmaceutical company focusing gastrointestinal and infectious diseases. It operates through the following segments: Commercial Operations and the Research & Development. The Commercial Operations segment covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Companyâ??s subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.